Zhao B T, Prince G, Horswood R, Eckels K, Summers P, Chanock R, Lai C J
Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892.
J Virol. 1987 Dec;61(12):4019-22. doi: 10.1128/JVI.61.12.4019-4022.1987.
A recombinant vaccinia virus containing cloned DNA sequences coding for the three structural proteins and nonstructural proteins NS1 and NS2a of dengue type 4 virus was constructed. Infection of CV-1 cells with this recombinant virus produced dengue virus structural proteins as well as the nonstructural protein NS1. These proteins were precipitated by specific antisera and exhibited the same molecular size and glycosylation patterns as authentic dengue virus proteins. Infection of cotton rats with the recombinant virus induced NS1 antibodies in 1 of 11 animals. However, an immune response to the PreM and E glycoproteins was not detected. A reduced level of gene expression was probably the reason for the limited serologic response to these dengue virus antigens.
构建了一种重组痘苗病毒,其含有编码4型登革病毒三种结构蛋白以及非结构蛋白NS1和NS2a的克隆DNA序列。用这种重组病毒感染CV-1细胞可产生登革病毒结构蛋白以及非结构蛋白NS1。这些蛋白可被特异性抗血清沉淀,并且表现出与天然登革病毒蛋白相同的分子大小和糖基化模式。用重组病毒感染棉鼠后,11只动物中有1只诱导产生了NS1抗体。然而,未检测到对前体膜(PreM)糖蛋白和包膜(E)糖蛋白的免疫反应。基因表达水平降低可能是对这些登革病毒抗原的血清学反应有限的原因。